Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Biotech
Novartis pays SciNeuro $165M for ticket on brain shuttle
Novartis’ continuing search for new ways to take drugs into the brain has resulted in a $1.7 billion deal with SciNeuro Pharmaceuticals.
James Waldron
Jan 12, 2026 8:49am
Cellular energy booster reverses advanced Alzheimer's in mice
Jan 2, 2026 12:42pm
Quanterix Alzheimer's test finds hidden cases in 40-year study
Dec 31, 2025 2:15pm
2 biotechs scrounge for funds in year-end dealmaking spree
Dec 23, 2025 1:45pm
Siemens Healthineers taps ALZpath for Alzheimer's blood test
Dec 16, 2025 2:00pm
Sanofi signs 2nd biotech deal of the day
Dec 15, 2025 5:50pm
